Company Announcement - MDxHealth SA will release its financial results for the first quarter ended March 31, 2025, after market close on May 14, 2025 [1] - A conference call will be held on the same day at 4:30pm ET / 22:30 CET, featuring CEO Michael K. McGarrity and CFO Ron Kalfus [2] Company Overview - MDxHealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment [3] - The company's tests utilize proprietary genomic, epigenetic (methylation), and other molecular technologies to assist in the diagnosis and prognosis of urologic cancers and diseases [3] - MDxHealth's U.S. headquarters and laboratory operations are located in Irvine, California, with additional operations in Plano, Texas, and European headquarters in Herstal, Belgium [3]